Patent · US Active

Mutant pore

US11939359B2 · kind B2 · utility

5Cited by
53References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 26, 2021
Grant dateMar 26, 2024
Priority date
Expiry dateJan 6, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/43504
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to mutant forms of lysenin. The invention also relates to analyte characterisation using the mutant forms of lysenin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.